Scarica l'app Stockscreener
8.31
1.59%
0.13
Dopo l'orario di chiusura:
8.50
0.19
+2.29%
Intellia Therapeutics Inc Borsa (NTLA) Ultime notizie
Cathie Wood’s ARK offloads Meta, boosts Intellia stock - Investing.com Australia
Cathie Wood’s ARK offloads Meta, boosts Intellia stock By Investing.com - Investing.com South Africa
Is Intellia Therapeutics Inc (NASDAQ:NTLA) A Better Buy Than Others After A -62.53% Fall In This Year? - Marketing Sentinel
Insider Sale Alert: Intellia Therapeutics Inc [NTLA] – Is it Time to sell? - knoxdaily.com
Lawsuit for Investors in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced by the Shareholders Foundation - PR Newswire
Wolfe Research Upgrades Intellia Therapeutics (NTLA) - Nasdaq
Intellia Therapeutics shares up after Wolfe upgrade - MSN
Intellia Therapeutics Shares Rise After Upgrade From Wolfe Research - marketscreener.com
Intellia Therapeutics (NTLA) Surges After Upgrade from Wolfe Research - GuruFocus
NTLA’s price-to-free cash flow ratio: What it means for investors - uspostnews.com
Intellia Therapeutics (NTLA) Advances Nex-z in Phase III Trial for ATTRv-PN - GuruFocus
Intellia Therapeutics (NTLA) Eyes Growth with Gene Editing Advances - GuruFocus
Intellia Therapeutics (NTLA) Receives Upgrade to Outperform from Wolfe Research | NTLA Stock News - GuruFocus
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Benzinga
New Horizons in Biomedical CRISPR Gene Editing Market Exploring - openPR.com
Wolfe Research Upgrades Intellia Therapeutics to Outperform From Peer Perform, Price Target is $21 - marketscreener.com
How the (NTLA) price action is used to our Advantage - news.stocktradersdaily.com
Intellia Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact The ... - Bluefield Daily Telegraph
Intellia Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
Final Deadline Today for the Intellia Therapeutics, Inc. Securit - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesNTLA - PR Newswire
NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Final Deadline Today for the Intellia Therapeutics, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsNTLA - The Malaysian Reserve
Class Action Filed Against Intellia Therapeutics, Inc. (NTLA)April 14, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - Business Wire
FINAL REMINDER NTLA DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Intellia Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit - markets.businessinsider.com
NTLA Investors are Reminded of the Final Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Malaysian Reserve
NTLA Lawsuit Alert! Class Action Lawsuit Against Intellia Therapeutics Inc. - TipRanks
Intellia Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before April 14, 2025 to Discuss Your RightsNTLA - PR Newswire
NTLA Deadline: NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar
FINAL NTLA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Intellia Therapeutics, Inc. Investors to Join the Class Action Lawsuit - markets.businessinsider.com
NTLA Investors Have the Opportunity to Lead the Intellia - GlobeNewswire
NTLA Investors Have the Opportunity to Lead the Intellia Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
NTLA DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. - Bluefield Daily Telegraph
NTLA DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire
התראת מועד אחרון לתביעה נגד NTLA: רוזן, למשקיעים מוכר, מעודד את משקיעי Intellia Therapeutics, Inc עם הפסדים העולים על 100 אלף דולר, להבטיח ייעוץ לפני המועד האחרון החשוב של 14 באפריל בתביעה ייצוגית בניירות ערך – NTLA - GlobeNewswire Inc.
Intellia Therapeutics, Inc. Investors: Please contact the - GlobeNewswire
NTLA Deadline: Rosen Law Firm Urges Intellia Therapeutics, Inc. (NASDAQ: NTLA) Stockholders with Losses in Excess of $50K to Contact the Firm for Information About Their Rights - Eagle-Tribune
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - PR Newswire
NTLA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Intellia Therapeutics, Inc. to Contact the Firm Today! - markets.businessinsider.com
The Gross Law Firm Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNTLA - PR Newswire
NTLA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, - GlobeNewswire
NTLA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. - Bluefield Daily Telegraph
Lost Money on Intellia Therapeutics, Inc. (NTLA)? Join - GlobeNewswire
Lost Money on Intellia Therapeutics, Inc. (NTLA)? Join Class Action Suit Seeking Recovery – ... - Bluefield Daily Telegraph
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - Morningstar
Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple - Insider Monkey
Vanguard Group Inc. Has $118.82 Million Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA) - Defense World
Intellia Therapeutics, Inc. (NASDAQ: NTLA) Investor Alert: Deadline in Lawsuit on April 14, 2025 - openPR.com
NTLA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Intellia Therapeutics, Inc. to Contact the Firm Today! - markets.businessinsider.com
Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) Seeking Recovery for InvestorsContact Levi & Korsinsky - Morningstar
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - StreetInsider
Intellia Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; April 14, 2025 Deadline to file Lead Plaintiff Motion - TradingView
0.24%
36.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):